We are live on
!
Find out more
CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
1-Year Est. Return
43.59%
This Fund
S&P 500
This Quarter
Est. Return
+17.74%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$954M
AUM Growth
+$43.5M
(+4.8%)
Cap. Flow
-$47.3M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
75.65%
Holding
29
New
6
Increased
8
Reduced
7
Closed
5
Top Buys
| 1 |
Corcept Therapeutics
CORT
|
+$45.4M |
| 2 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$45.3M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
+$36.3M |
| 4 |
Globus Medical
GMED
|
+$29.3M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$20M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$84.9M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$44.2M |
| 3 |
Pediatrix Medical
MD
|
+$44M |
| 4 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$37M |
| 5 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$35.7M |
Sector Composition
| 1 | Healthcare | 99.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $91.9M | 9.63% |
6,218,903
+425,000
| +7% | +$6.88M |
|
2
United Therapeutics
UTHR
$22.6B
| $86.9M | 9.11% |
642,168
+61,467
| +11% | +$9.31M |
|
|
3
Globus Medical
GMED
$10.7B
| $86.9M | 9.11% |
2,935,000
+1,075,000
| +58% | +$29.3M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $85M | 8.91% |
1,334,467
-1,396,420
| -51% | -$84.9M |
|
|
AMRN
5
Amarin Corp
AMRN
$303M
| $80.2M | 8.4% |
1,252,619
| – | – |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $69.5M | 7.28% |
1,558,944
+405,000
| +35% | +$20M |
|
7
Myriad Genetics
MYGN
$596M
| $57.1M | 5.99% |
2,976,356
+647,424
| +28% | +$11.5M |
|
|
8
Corcept Therapeutics
CORT
$9.62B
| $56.7M | 5.94% |
+5,169,640
| New | +$45.4M |
|
9
AtriCure
ATRC
$1.75B
| $55.3M | 5.79% |
2,886,354
+220,000
| +8% | +$3.85M |
|
|
AAAP
10
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $52.3M | 5.48% |
+1,311,855
| New | +$45.3M |
|
11
Pacira BioSciences
PCRX
$997M
| $44.3M | 4.65% |
972,535
+340,730
| +54% | +$14.7M |
|
|
LJPC
12
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $42.4M | 4.44% |
+1,420,742
| New | +$36.3M |
|
13
Travere Therapeutics
TVTX
$5.28B
| $39.4M | 4.13% |
2,132,140
-640,016
| -23% | -$12.5M |
|
|
NVDQ
14
DELISTED
Novadaq Technologies Inc.
NVDQ
| $23.5M | 2.46% |
3,018,179
+605,000
| +25% | +$4.29M |
|
|
CVRS
15
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $19.8M | 2.08% |
+15,114,872
| New | +$12.3M |
|
16
Acadia Healthcare
ACHC
$2.97B
| $13.5M | 1.42% |
310,666
-200,000
| -39% | -$8.12M |
|
|
ACOR
17
DELISTED
Acorda Therapeutics
ACOR
| $13M | 1.36% |
+5,162
| New | +$14.9M |
|
|
ARRY
18
DELISTED
Array Biopharma Inc
ARRY
| $12.3M | 1.29% |
1,373,471
-1,350,000
| -50% | -$14.4M |
|
19
Vericel Corp
VCEL
$2.39B
| $8.35M | 0.88% |
2,982,940
| – | – |
|
20
ANI Pharmaceuticals
ANIP
$1.84B
| $7.08M | 0.74% |
143,003
-348,605
| -71% | -$19.6M |
|
21
ADMA Biologics
ADMA
$2.01B
| $6.22M | 0.65% |
1,273,933
| – | – |
|
|
BIOL
22
DELISTED
Biolase, Inc.
BIOL
| $1.7M | 0.18% |
101
-15
| -13% | -$272K |
|
|
SPNE
23
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $692K | 0.07% |
88,127
-40,000
| -31% | -$289K |
|
|
SBBP
24
DELISTED
Strongbridge Biopharma plc.
SBBP
| $48K | 0.01% |
+10,000
| New | +$30.6K |
|
|
25
Pediatrix Medical
MD
$2.13B
| – | – |
-660,000
| Closed | -$44M |
|
Similar funds
GPC
BPM
TVPI
DCI
TPMI
TP
SCG
CVGI